2min chapter

The Foresight Institute Podcast cover image

Nir Barzilai | Targeting Aging with Metformin

The Foresight Institute Podcast

CHAPTER

Metformin Is a Tool to Target Aging and Delay Aging

The DPP trial took non diabetic people and gave them metformin and showed a 30% decrease in the rate of diabetes over four years. Another intervention study was the UKT PDS, where it showed that midforming, unlike insulin or other drugs, sulfonyl or ria other drugs, the Chris cardiovascular disease by 36%. And overall mortality by 36%. Next, their association studies are not as good as as intervention studies. But if you have 200 of them, and there are more that are all showing, you know, when you're in midformin you have less cancers, and it's all cause of cancer. Because of those reasons we use metformin as a

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode